Duration of the Mosquitocidal Effect of Ivermectin

Overview

Journal Malariaworld J

Date 2024 Jun 10

PMID 38854885

Authors

Guido J H Bastiaens

Geert-Jan vanGemert

Jo Hooghof

Steve W Lindsay

Chris Drakeley

Thomas S Churcher

Jan Peter Verhave

Clemens H M Kocken

Robert W Sauerwein

Teun Bousema

Affiliations

Soon will be listed here.

Abstract

Background: Ivermectin (IVM) reduces the lifespan of malaria-transmitting mosquitoes after feeding on humans treated with IVM. If this effect is sufficiently long and strong, IVM could form part of a drug combination that not only treats malaria patients but also reduces onward transmission. Limited data are available on the exact duration of the mosquitocidal effect of IVM; daily mosquito feeding assays are required for this.

Materials And Methods: We determined mortality rates of mosquitoes that took a blood meal on Swiss mice, Wistar rats and Cynomolgus monkeys that received IVM orally at 200-400 μg/kg. Mosquito feeding assays were performed on five consecutive days after IVM administration. Mosquito mortality was determined in the first 72 hours after feeding.

Results: Mosquito mortality was 70-100% when mosquitoes fed on any of the animals 1-2 days after the last IVM administration. After this time-point the mosquitocidal effect was still evident in some animals but became more variable.

Conclusions: Our findings of a pronounced but short-lived mosquitocidal effect makes the timing of IVM administration crucial to form a useful addition to anti-malarial drugs.

Citing Articles

Evaluation of the mosquitocidal efficacy of fluralaner, a potential candidate for drug based vector control.

Shah H, Srinivasan V, Venkatesan S, Balakrishnan V, Candasamy S, Mathew N Sci Rep. 2024; 14(1):5628.

PMID: 38454095 PMC: 10920869. DOI: 10.1038/s41598-024-56053-x.

BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two....

Chaccour C, Casellas A, Hammann F, Ruiz-Castillo P, Nicolas P, Montana J Trials. 2023; 24(1):128.

PMID: 36810194 PMC: 9942013. DOI: 10.1186/s13063-023-07098-2.

Ivermectin as an endectocide may boost control of malaria vectors in India and contribute to elimination.

Ahmad S, Rahi M, Saroha P, Sharma A Parasit Vectors. 2022; 15(1):20.

PMID: 35012612 PMC: 8744265. DOI: 10.1186/s13071-021-05124-3.

Fipronil and ivermectin treatment of cattle reduced the survival and ovarian development of field-collected Anopheles albimanus in a pilot trial conducted in northern Belize.

Dreyer S, Leiva D, Magana M, Pott M, Kay J, Cruz A Malar J. 2019; 18(1):296.

PMID: 31464619 PMC: 6716933. DOI: 10.1186/s12936-019-2932-6.

Filling gaps on ivermectin knowledge: effects on the survival and reproduction of Anopheles aquasalis, a Latin American malaria vector.

Sampaio V, Beltran T, Kobylinski K, Melo G, Lima J, Silva S Malar J. 2016; 15(1):491.

PMID: 27660149 PMC: 5034551. DOI: 10.1186/s12936-016-1540-y.

References

Bockarie M, Hii J, Alexander N, Bockarie F, Dagoro H, Kazura J . Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival. Med Vet Entomol. 1999; 13(2):120-3. DOI: 10.1046/j.1365-2915.1999.00159.x. View

Kane N, HIRSCHBERG B, Qian S, Hunt D, Thomas B, Brochu R . Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin. Proc Natl Acad Sci U S A. 2000; 97(25):13949-54. PMC: 17681. DOI: 10.1073/pnas.240464697. View

Bousema T, Okell L, Shekalaghe S, Griffin J, Omar S, Sawa P . Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J. 2010; 9:136. PMC: 2881938. DOI: 10.1186/1475-2875-9-136. View

Bousema J, Schneider P, Gouagna L, Drakeley C, Tostmann A, Houben R . Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis. 2006; 193(8):1151-9. DOI: 10.1086/503051. View

Schneider P, Bousema J, Gouagna L, Otieno S, van de Vegte-Bolmer M, Omar S . Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg. 2007; 76(3):470-4. View

Foy B, Kobylinski K, da Silva I, Rasgon J, Sylla M . Endectocides for malaria control. Trends Parasitol. 2011; 27(10):423-8. PMC: 3178713. DOI: 10.1016/j.pt.2011.05.007. View

Sylla M, Kobylinski K, Gray M, Chapman P, Sarr M, Rasgon J . Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors. Malar J. 2010; 9:365. PMC: 3016374. DOI: 10.1186/1475-2875-9-365. View

Iakubovich V, ZAKHAROVA N, Alekseev A, Alekseev E . [Evaluation of the action of ivermectin on blood-sucking mosquitoes]. Med Parazitol (Mosk). 1989; (3):60-4. View

Kobylinski K, Deus K, Butters M, Hongyu T, Gray M, da Silva I . The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors. Acta Trop. 2010; 116(2):119-26. PMC: 2939250. DOI: 10.1016/j.actatropica.2010.06.001. View

10.

Fritz M, Walker E, Miller J . Lethal and sublethal effects of avermectin/milbemycin parasiticides on the African malaria vector, Anopheles arabiensis. J Med Entomol. 2012; 49(2):326-31. DOI: 10.1603/me11098. View

11.

Shekalaghe S, ter Braak R, Daou M, Kavishe R, van den Bijllaardt W, van den Bosch S . In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob Agents Chemother. 2010; 54(5):1762-8. PMC: 2863610. DOI: 10.1128/AAC.01135-09. View

12.

Baird J, Surjadjaja C . Consideration of ethics in primaquine therapy against malaria transmission. Trends Parasitol. 2010; 27(1):11-6. DOI: 10.1016/j.pt.2010.08.005. View

13.

Foley D, Bryan J, Lawrence G . The potential of ivermectin to control the malaria vector Anopheles farauti. Trans R Soc Trop Med Hyg. 2001; 94(6):625-8. DOI: 10.1016/s0035-9203(00)90211-6. View

14.

Moonen B, Cohen J, Snow R, Slutsker L, Drakeley C, Smith D . Operational strategies to achieve and maintain malaria elimination. Lancet. 2010; 376(9752):1592-603. PMC: 3037542. DOI: 10.1016/S0140-6736(10)61269-X. View

15.

Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, Deen J . Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis. 2001; 183(8):1254-9. DOI: 10.1086/319689. View

16.

Fritz M, Siegert P, Walker E, Bayoh M, Vulule J, Miller J . Toxicity of bloodmeals from ivermectin-treated cattle to Anopheles gambiae s.l. Ann Trop Med Parasitol. 2009; 103(6):539-47. DOI: 10.1179/000349809X12459740922138. View

17.

Chaccour C, Lines J, Whitty C . Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control. J Infect Dis. 2010; 202(1):113-6. DOI: 10.1086/653208. View

18.

Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A . Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One. 2007; 2(10):e1023. PMC: 1995753. DOI: 10.1371/journal.pone.0001023. View

19.

Sutherland C, Ord R, Dunyo S, Jawara M, Drakeley C, Alexander N . Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Med. 2005; 2(4):e92. PMC: 1087200. DOI: 10.1371/journal.pmed.0020092. View

20.

Coulibaly B, Zoungrana A, Mockenhaupt F, Schirmer R, Klose C, Mansmann U . Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS One. 2009; 4(5):e5318. PMC: 2673582. DOI: 10.1371/journal.pone.0005318. View